Apogee Therapeutics to Host Conference Call to Report Part A 16-Week Data from the Phase 2 APEX Trial of APG777 in Patients with Moderate-to-Severe Atopic Dermatitis on July 7, 2025
SAN FRANCISCO and BOSTON, July 06, 2025 (GLOBE NEWSWIRE) -- Apogee Therapeutics,…
HUTCHMED to Announce 2025 Half-Year Financial Results
July 03, 2025 04:30 ET Â | Source: HUTCHMED (China) Limited HONG KONG…
Sandisk Announces Participation in Investor Conference
MILPITAS, Calif.--(BUSINESS WIRE)--Sandisk Corporation (NASDAQ: SNDK) announced today that management will participate…
PolyPid to Host Conference Call and Webcast to Discuss D-PLEX SHIELD II Phase 3 Trial Topline Results on Monday, June 9, 2025
June 06, 2025 16:05 ET  | Source: PolyPid Ltd. PETACH TIKVA, Israel, June…
KKR to Present at the Morgan Stanley US Financials Conference 2025
NEW YORK--(BUSINESS WIRE)--KKR & Co. Inc. (NYSE: KKR) announced today that Adam…